Transgene

๐Ÿ“ Illkirch-Graffenstaden, France๐Ÿ—“ Founded 1979๐Ÿ‘ฅ 206 employees๐Ÿ’ฐ Last funded Dec 2015
Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1979
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Transgene?
Transgene has 1 investors on record on gritt.io.
When did Transgene last raise funding?
The most recent investment in Transgene recorded on gritt.io was in December 2015.
When was Transgene founded?
Transgene was founded in 1979.
What industry is Transgene in?
Transgene operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Transgene based?
Transgene is headquartered in Illkirch-Graffenstaden, France.